XML 55 R48.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue Interest Purchase Agreement - Additional Information (Details) - Purchase Agreement - OrbiMed - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 12, 2022
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2025
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Upfront payment received $ 125,000,000          
Potential revenue interest second payment to be received $ 75,000,000          
Purchase agreement, second payment date Sep. 12, 2025          
Potential revenue interest third payment to be received $ 50,000,000          
Purchase agreement, third payment date Sep. 12, 2025          
Revenue interest payment term 45 days          
Amortization of purchase agreement obligation         $ 0  
Effective interest rate   8.80%     8.80%  
Debt issuance costs   $ 600,000     $ 600,000  
Revenue interest payable   $ 4,698,000 $ 2,944,000 $ 2,623,000 $ 4,700,000 $ 2,400,000
Maximum            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Potential revenue interest payment to be received $ 125,000,000